Zingavita
Signals mentioning Zingavita
- Honasa slips 3% after ₹135 cr Fluence Pharma deal to enter nutraceuticals
- Honasa Buys 58% Of Fluence Pharma, Pushes Mamaearth Into Beauty-From-Within
- Honasa Consumer hires two senior leaders to build new brands beyond Mamaearth